TABLE 5.

Report-odds ratio (ROR) and Proportional Report-ratio (PRR) analysis of the top three most common drug classes associated with kidney stone formation in the FDA FAERS database from 1 January 2010 to 31 March 2024.

Ranking	Drug classification	a	b	c	d	ROR	ROR lower bound, 95% CI	ROR upper bound, 95% CI	PRR
1	Antirheumatics	17,698	15,404,821	20,083	36,716,719	2.1	2.06	2.14	2.1
2	Parathyroid hormone and analogs	3,678	2,026,199	34,103	50,095,341	2.67	2.58	2.76	2.66
3	Antiviral drug	2,890	1,685,034	34,891	50,436,506	2.48	2.39	2.58	2.48